e-learning
resources
Paris 2018
Monday, 17.09.2018
Critically ill patients: prognostic factors and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of body mass index on B-type natriuretic peptide levels in critically ill patients
J. Hwang (Seoul, Republic of Korea), S. Han (Seoul, Republic of Korea), Y. Jo (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea)
Source:
International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Session:
Critically ill patients: prognostic factors and biomarkers
Session type:
Thematic Poster
Number:
2306
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Hwang (Seoul, Republic of Korea), S. Han (Seoul, Republic of Korea), Y. Jo (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea). Effect of body mass index on B-type natriuretic peptide levels in critically ill patients. 2306
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Definition and history of sarcoidosis
Related content which might interest you:
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
N-terminal pro-B-type natriuretic peptide in non-surgical critically ill patents
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
The role of pro-brain natriuretic peptide and C-reactive protein as prognostic markers in stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Serum levels of high sensitivity cardiac troponin and B-type natriuretic peptide in patients with COPD-OSA overlap syndrome
Source: Sleep and Breathing Conference 2021
Year: 2021
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 279s
Year: 2004
Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019
Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism
Source: Eur Respir J 2014; 43: 1669-1677
Year: 2014
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Effects of steroid treatment on serum leptin level and haemostatic parameters in COPD patients with normal body mass index
Source: Eur Respir J 2006; 28: Suppl. 50, 30s
Year: 2006
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020
Year: 2020
Influence of antibiotic pre-treatment on pro-atrial natriuretic peptide in community-acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Utility of N-terminal pro b-type natriuretic peptide (NT-PROBNP) dosage in differential diagnosis of acute dyspnoea
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept